Veracyte Inc (FRA:12V)
€ 32 0.6 (1.91%) Market Cap: 2.54 Bil Enterprise Value: 2.34 Bil PE Ratio: 0 PB Ratio: 2.37 GF Score: 83/100

Veracyte Inc Annual Shareholders Meeting Transcript

Jun 05, 2020 / 04:00PM GMT
Release Date Price: €22.2 (-3.48%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Veracyte Annual Meeting. (Operator Instructions)

I would now like to turn the call over to Ms. Bonnie Anderson. Ma'am, you may begin.

Bonnie H. Anderson
Veracyte, Inc. - Co-Founder, Chairman & CEO

Thank you. Good morning, ladies and gentlemen, and welcome to the 2020 Annual Meeting of Stockholders of Veracyte. My name is Bonnie Anderson, and I'm the Chairman of the Board and Chief Executive Officer of the company. I will be serving as the Chairwoman of the meeting as we proceed. And Keith Kennedy, our Chief Operating Officer and Chief Financial Officer, will serve as Secretary of the meeting. Thank you for being here today.

The meeting is now called to order. First, a few introductions. I would like to introduce the directors of Veracyte, who are present on the line today, Dr. Fred Cohen; Karin Eastham; Dr. Robert Epstein; Evan Jones; and Kevin Gordon.

I would also like to introduce representatives of Ernst & Young LLP, our auditing firm, who are present

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot